Circassia Group PLC Registered Shares o.N.

Sector and Industry

Healthcare, Healthcare Equipment

Performance (1Y)

12.50%

Market Cap

288.29 Mil.

P/E Ratio

39.29

Dividend Yield

2.33 %

Earnings per Share

0.02 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Abbott Laboratories185.26 Bil.39.29 Bil.33.69
-53.32 %
0.00
-
Intuitive Surgical Inc171.24 Bil.8.92 Bil.71.93
+17.90 %
0.00
-
Boston Scientific Corp120.40 Bil.17.79 Bil.49.17
+49.88 %
0.00
-
Stryker Corp.114.47 Bil.22.26 Bil.41.85
+3.99 %
0.00
-
Medtronic PLC90.93 Bil.31.27 Bil.22.35
-4.61 %
0.00
-
Siemens Healthineers AG51.40 Bil.23.38 Bil.24.04
+10.40 %
0.00
-
Hoya Corp48.59 Bil.5.43 Bil.35.69
+17.33 %
0.00
-
Becton Dickinson and Co.45.46 Bil.19.79 Bil.32.18
-3.33 %
0.00
-
Edwards Lifesciences Corp42.15 Bil.5.38 Bil.47.11
-27.44 %
0.00
-
Alcon AG33.20 Bil.9.24 Bil.38.41
-7.56 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE0.7 G0 Units
PRICE DETERMINATION TIME07/22/2026 / 06:34:26 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW0.730.68
PREV. DAY'S PRICE0.685 (07/21)
CHANGE DAY BEFORE
+0.01
2.19 %
52 WEEK HIGH / LOW0.9 (10/06)0.595 (03/24)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
0.030.010.020.040.04
DIVIDENDS PER SHARE
0.010.010.020.020.02
DIVIDEND YIELD IN %
1.49 %1.98 %2.33 %--
DIVIDEND GROWTH IN %
-28.41 %22.67 %--
PRICE - EARNINGS RATIO
26.2771.5939.2917.6115.55
PRICE - BOOK RATIO
3.373.823.77--
PRICE - SALES RATIO
8.186.765.81--
PRICE - CASH FLOW RATIO
24.6715.6917.91--
Further Key Figures

Master Data

WKN
A1XFBM
ISIN
GB00BJVD3B28
SYMBOL
82C
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
CIRCASSIA GROUP PLC
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
British Pound Sterling
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Healthcare Equipment
NUMBER OF SHARES
420.87 Mil.
MARKET CAPITALISATION
288.29 Mil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
3.10 %
4.72 %
3.91 %
-7.64 %
-12.50 %
-10.74 %
107.81 %
-5.67 %
HIGH0.690.690.820.820.900.900.900.82
LOW0.630.600.600.600.600.590.310.60

Dividende

pro Aktie

Company profile

Niox Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis and management of asthma. It offers NIOX VERO, a non-invasive point-of-care system that provides fractional exhaled nitric oxide (FeNO) measurements. The company was founded by Steven Harris and Charles Stuart Webb Swingland on May 19, 2006 and is headquartered in Oxford, the United Kingdom.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.